Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-23 · accession 0001193125-26-024600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2026-01-23 | PHAT | Parikh Asit | Dir | G - Gift | $0.00 | -80.5K | 50.5K | -61% | $0 | |
| I | 2026-01-27 | 2026-01-23 | PHAT | Parikh Asit | Dir | G - Gift | $0.00 | +80.5K | 80.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-23 | G | D | 80,500 | $0.00 | 50,500 | D by Trust | — | — | (F2) The shares are subject to a lock-up agreement entered into by the Reporting Person in connection with the underwriting agreement dated January 7, 2026 (the Lock-Up Agreement). The trust has agreed in writing to be bound by the same terms described in the Lock-Up Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer. |
| 2 | Common | Common Stock | 2026-01-23 | G | A | 80,500 | $0.00 | 80,500 | I | — | — | (F1) Reflects shares transferred for no consideration to a trust for the benefit of the Reporting Person's spouse and for which the Reporting Person serves as trustee. |